Lam Research Corp LRCX
We take great care to ensure that the data presented and summarized in this overview for LAM RESEARCH CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding LRCX
View all-
Black Rock Inc. New York, NY12.9MShares$1.02 Billion0.32% of portfolio
-
Menora Mivtachim Holdings Ltd.1.38MShares$109 Million0.63% of portfolio
-
Kovitz Investment Group Partners, LLC1.34MShares$106 Million0.34% of portfolio
-
Pictet Asset Management Sa Geneva 73, V8466KShares$36.8 Million0.36% of portfolio
-
Cibc World Markets Corp New York, NY251KShares$19.8 Million0.11% of portfolio
-
Credit Suisse Ag Zurich, V8242KShares$19.1 Million0.23% of portfolio
-
Eaton Vance Management Boston, MA225KShares$17.8 Million0.12% of portfolio
-
Avalon Investment & Advisory Houston, TX225KShares$17.8 Million3.35% of portfolio
-
Agf Investments Inc. Toronto, A6201KShares$15.9 Million0.69% of portfolio
-
Mediolanum International Funds LTD Dublin 1, L2196KShares$15.5 Million0.18% of portfolio
Latest Institutional Activity in LRCX
Top Purchases
Top Sells
About LRCX
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products. It also provides SPEED gapfill high-density plasma chemical vapor deposition products; and Striker single-wafer atomic layer deposition products for dielectric film solutions. In addition, the company offers Flex for dielectric etch applications; Kiyo for conductor etch applications; Syndion for through-silicon via etch applications; and Versys metal products for metal etch processes. Further, it provides Coronus bevel clean products to enhance die yield; Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications; and Metryx mass metrology systems for high precision in-line mass measurement in semiconductor wafer manufacturing. The company sells its products and services to semiconductors industry in the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and internationally. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.
Insider Transactions at LRCX
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 28
2025
|
Timothy Archer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,111
-0.82%
|
$616,436
$76.74 P/Share
|
Mar 28
2025
|
Douglas R Bettinger Chief Financial Officer & EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
2,186
-0.21%
|
$166,136
$76.74 P/Share
|
Feb 28
2025
|
Timothy Archer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
61,254
-1.97%
|
$4,655,304
$76.74 P/Share
|
Feb 28
2025
|
Timothy Archer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
118,500
+10.13%
|
-
|
Feb 28
2025
|
Douglas R Bettinger Chief Financial Officer & EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
15,645
-0.5%
|
$1,189,020
$76.74 P/Share
|
Feb 28
2025
|
Douglas R Bettinger Chief Financial Officer & EVP |
BUY
Grant, award, or other acquisition
|
Direct |
33,435
+3.1%
|
-
|
Feb 28
2025
|
Vahid Vahedi Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
13,908
-1.11%
|
$1,057,008
$76.74 P/Share
|
Feb 28
2025
|
Vahid Vahedi Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
20,467
+6.07%
|
-
|
Feb 28
2025
|
Patrick J Lord Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
14,180
-4.18%
|
$1,077,680
$76.74 P/Share
|
Feb 28
2025
|
Patrick J Lord Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
27,043
+23.24%
|
-
|
Feb 28
2025
|
Seshasayee Varadarajan Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
15,032
-1.83%
|
$1,142,432
$76.74 P/Share
|
Feb 28
2025
|
Seshasayee Varadarajan Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
31,253
+12.94%
|
-
|
Feb 28
2025
|
Neil J Fernandes Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
6,226
-2.08%
|
$473,176
$76.74 P/Share
|
Feb 28
2025
|
Neil J Fernandes Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
19,913
+20.53%
|
-
|
Feb 28
2025
|
Christina Corrreia CVP , Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,113
-1.46%
|
$236,588
$76.74 P/Share
|
Feb 28
2025
|
Christina Corrreia CVP , Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,604
+13.66%
|
-
|
Feb 28
2025
|
Ava Harter Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,383
-2.08%
|
$105,108
$76.74 P/Share
|
Feb 28
2025
|
Ava Harter Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,360
+22.57%
|
-
|
Feb 20
2025
|
Seshasayee Varadarajan Senior Vice President |
SELL
Open market or private sale
|
Direct |
110,080
-22.99%
|
$9,907,200
$90.0 P/Share
|
Feb 20
2025
|
Seshasayee Varadarajan Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
110,080
+18.47%
|
$1,981,440
$18.35 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 314K shares |
---|---|
Other acquisition or disposition | 32.6K shares |
Exercise of conversion of derivative security | 296K shares |
Other acquisition or disposition | 32.6K shares |
---|---|
Open market or private sale | 169K shares |
Payment of exercise price or tax liability | 142K shares |
Bona fide gift | 182 shares |